miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction

Wang, Liang; Sun, Liankang; Wang, Yufeng; Yao, Bowen; Liu, Runkun; Chen, Tianxiang; Tu, Kangsheng; Liu, Qingguang; Liu, Zhikui

doi:10.7150/ijbs.75583



PDF

Int J Biol Sci 2022; 18(10):3942. doi:10.7150/ijbs.75583 This issue Cite

Retraction

miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction

Liang Wang, Liankang Sun, Yufeng Wang, Bowen Yao, Runkun Liu, Tianxiang Chen, Kangsheng Tu, Qingguang Liu, Zhikui Liu

Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China, 710061.

Citation:

Wang L, Sun L, Wang Y, Yao B, Liu R, Chen T, Tu K, Liu Q, Liu Z. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction. Int J Biol Sci 2022; 18(10):3942. doi:10.7150/ijbs.75583. https://www.ijbs.com/v18p3942.htm

Other styles

Retracted-article in Int J Biol Sci, Volume 15, 1514

This retracts the article “miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418” in Int J Biol Sci 2019; 15(7): 1514-1522. doi: 10.7150/ijbs.33658.

The article (miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418) has been retracted since the authors noticed that there were some unreliable data in the experimental validations. After careful consideration, the authors decided to retract this article. We truly regret any inconvenience caused by our careless and do apologize for any unintentional mistakes.

All authors have agreed to the retraction of the article.

Author contact

Corresponding author: Zhikui Liu, Ph.D., MD, Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an 710061, China. E-mail: liuzhikui.1234com; Phone: +086-029-85323905; Fax: +086-029-85323209

Published 2022-6-7

Citation styles

APA

Wang, L., Sun, L., Wang, Y., Yao, B., Liu, R., Chen, T., Tu, K., Liu, Q., Liu, Z. (2022). miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction. International Journal of Biological Sciences, 18(10), 3942. https://doi.org/10.7150/ijbs.75583.

ACS

Wang, L.; Sun, L.; Wang, Y.; Yao, B.; Liu, R.; Chen, T.; Tu, K.; Liu, Q.; Liu, Z. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction. Int. J. Biol. Sci. 2022, 18 (10), 3942. DOI: 10.7150/ijbs.75583.

NLM

CSE

Wang L, Sun L, Wang Y, Yao B, Liu R, Chen T, Tu K, Liu Q, Liu Z. 2022. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction. Int J Biol Sci. 18(10):3942.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.